Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Avadel Pharmaceuticals plc (NASDAQ: AVDL) was $9.29 for the day, down -1.59% from the previous closing price of $9.44. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 0.68 million shares were traded. AVDL stock price reached its highest trading level at $9.6999 during the session, while it also had its lowest trading level at $9.26.
Ratios:
Our analysis of AVDL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.73. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On June 12, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $27.
Oppenheimer reiterated its Outperform rating for the stock on March 05, 2024, while the target price for the stock was revised from $27 to $29.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 21 ’25 when Palczuk Linda bought 5,000 shares for $7.93 per share. The transaction valued at 39,640 led to the insider holds 67,900 shares of the business.
Thornton Peter J. bought 10,000 shares of AVDL for $80,450 on Jan 13 ’25. The Director now owns 104,055 shares after completing the transaction at $8.04 per share. On Jan 13 ’25, another insider, Ende Eric J, who serves as the Director of the company, bought 30,000 shares for $7.84 each. As a result, the insider paid 235,218 and bolstered with 208,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 900205632 and an Enterprise Value of 872602688. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.63 while its Price-to-Book (P/B) ratio in mrq is 12.12. Its current Enterprise Value per Revenue stands at 4.488 whereas that against EBITDA is -53.207.
Stock Price History:
The Beta on a monthly basis for AVDL is 1.45, which has changed by -0.33926034 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, AVDL has reached a high of $17.30, while it has fallen to a 52-week low of $6.38. The 50-Day Moving Average of the stock is 2.18%, while the 200-Day Moving Average is calculated to be -8.08%.
Shares Statistics:
AVDL traded an average of 1.34M shares per day over the past three months and 2011780 shares per day over the past ten days. A total of 96.63M shares are outstanding, with a floating share count of 88.51M. Insiders hold about 8.65% of the company’s shares, while institutions hold 77.00% stake in the company. Shares short for AVDL as of 1749772800 were 10615388 with a Short Ratio of 7.92, compared to 1747267200 on 10761809. Therefore, it implies a Short% of Shares Outstanding of 10615388 and a Short% of Float of 12.8.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
